Feed KMDA
KM

Kamada Ltd. KMDA · NASDAQ

$7.73 -0.64% (-$0.05)

Summary

64 / 100 · Bulios Score

What speaks for it

  • It holds more cash than debt: $29.5M against $11.8M.
  • The share price is below the Bulios Fair Price.
  • Out of every 100 USD of revenue, 12 USD is left as net profit.
  • Revenue grew by 12% a year over the last 3 years.

What to watch

  • It pays out more in dividends than it earns: 109% of profit.
  • Earnings per share swing sharply from year to year.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $7.73
P/E today 20.0 29% lower
5-year average P/E 28.1
P/E today 20.0
Drug Manufacturers - Specialty & Generic industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 20.0 USD for 1 USD of yearly profit. Over the last five years it was 28.1 USD on average.

Valuation in detail

Is it growing?

Slowly

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 6.3% a year over 5 years. Over the last 3 years it grew by 12% a year.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Net profit, industry median (Drug Manufacturers - Specialty & Generic) 10 USD

Out of every 100 USD of revenue, 12 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

It could repay all its debt from a single year of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

High, at risk
Yield
5.43%
Paid out of profit
109%

You receive $0.42 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $15 is 94% above today's price. 83% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

Distribution Member brings in 100% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.